Key facts
- This page summarizes Stephen I. Sadove's Form 4 filing for COLGATE PALMOLIVE CO (CL).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 17 May 2023, 16:10.
Stephen I. Sadove - 15 May 2023 Form 4 Insider Report for COLGATE PALMOLIVE CO (CL)
- Reporting relationship
- Director
- Issuer ticker
- CL
- Reported as of
- 15 May 2023
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 17 May 2023, 16:10:50 UTC
- Prior SEC filing
- 05 May 2023
- Next SEC filing
- 02 Jun 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Kristine Hutchinson, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Stephen I. Sadove filed Form 4 for COLGATE PALMOLIVE CO (CL) on 17 May 2023.
Change
- Previous filing in this sequence was filed on 05 May 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CL
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +2,220
- Change %
- +24%
- Price
- $0.000000
- Shares after
- 11,440
- Date
- 15 May 2023
- Ownership
- By Trust
- Footnotes
- F1
CL
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 11,937
- Date
- 15 May 2023
- Ownership
- Direct
CL
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 13,000
- Date
- 15 May 2023
- Ownership
- By Family Trust
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CL
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +2,884
- Change %
- Price
- $0.000000
- Shares after
- 2,884
- Date
- 15 May 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 2,884
- Exercise price
- $81.08
- Footnotes
- F2, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Annual director stock grant under the issuer's incentive compensation plan.
Footnote F2
Annual director stock option grant under the issuer's incentive compensation plan.
Footnote F3
Option becomes exercisable in equal annual installments over three years beginning on the first anniversary of the May 15, 2023 grant date.